| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa554c54a7cc89b2991d3e8a508efcaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_57b7b2446fae277e03b6fa11fe675df0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-7155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-521
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70578
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-347
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-5434 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2019-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9d3153fd9c63dc5522840e37d7fc6e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63e0f89dbb762e2966fb3f9cda28b688
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b18ef776d92779d56af3b02e4be8d530
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e02dc7809e6536350cbd63c6a469e1ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e51931348fbddf962f4a19308148b9d |
| publicationDate |
2019-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019180463-A1 |
| titleOfInvention |
Biomarker combination for identification of "at-risk" subjects for aki |
| abstract |
A method for determining predisposition of a subject to developing renal dysfunction (AKI), and to a kit for use in making such a determination is provided. Suitably at least one marker selected from Midkine (MK) or H-FABP present in a blood or urine sample is used in the method. |
| priorityDate |
2018-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |